Stage I NSCLC patients who receive radiation therapy are surviving longer

September 6, 2012, American Society for Radiation Oncology

Stage I, non-small cell lung cancer (NSCLC) patients who received radiation therapy have an increased median survival of 21 months compared to 16 months, and the percentage of patients who receive no treatment declined from 20 percent to 16 percent, respectively, when comparing the two eras evaluated, 1999-2003 and 2004-2008, according to detailed analysis of the SEER-17 (Surveillance Epidemiology and End Results, National Cancer Institute) national database presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology. This symposium is sponsored by the American Society of Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO), the International Association for the Study of Lung Cancer (IASLC) and The University of Chicago.

Stage I NSCLC has traditionally been treated effectively with surgery in patients who are otherwise healthy. For patients who are not good candidates for surgery, technological advances in radiation therapy have allowed for high-dose, targeted, non-invasive and painless as an alternative curative option. This study evaluated 53,764 patients with stage I NSCLC—27,469 from 1999-2003 and 26,195 from 2004-2008. The data demonstrated a 12-month increased overall survival for all patients with Stage I disease in the later era—from 44 months to 56 months. The proportion of patients who received surgery increased from 64 percent to 70 percent, while the proportion of patients who were treated with radiation therapy alone was relatively stable at 14 percent and 13 percent in the later era. The number of patients who received neither radiation or surgery remained high for both eras—5, 514 patients, or 20 percent, from the earlier period, and 4,218, or 16 percent, in the later time frame.

"Stage I NSCLC patients who receive alone are surviving longer than they used to," said lead author Nirav S. Kapadia, MD, a chief resident in the department of at the University of Michigan Medical School in Ann Arbor, Mich. "However, at least 16 percent of patients are still not getting the care that they need—care that could save their lives. We must identify the barriers to treatment so that every patient has hope for a cancer cure."

Explore further: Elderly Dutch lung patients' survival improved by new treatment options between 2003-2009

More information: The abstract, "Patterns of Practice and Outcomes for Stage I, NSCLC: Analysis of SEER-17 Data 1999-2008," will be presented during the Poster Discussion at 5:30 p.m., Central time on September 6, 2012.

Related Stories

Elderly Dutch lung patients' survival improved by new treatment options between 2003-2009

July 6, 2011
New developments such as stereotactic ablative radiotherapy and improvements in surgical care in early-stage lung cancer have led to large survival gains for elderly Dutch patients, according to a population-based study presented ...

SBRT provides better outcomes than surgery for cancer patients with common lung disease

February 16, 2012
Stereotactic body radiotherapy (SBRT) provides better overall survival rates than surgery for lung cancer patients with severe chronic obstructive pulmonary disease (COPD), a disease commonly associated with lung cancer, ...

Recommended for you

Presurgical targeted therapy delays relapse of high-risk stage 3 melanoma

January 17, 2018
A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression compared to standard-of-care surgery for patients with stage 3 disease, researchers at ...

Dulling cancer therapy's double-edged sword

January 17, 2018
Researchers have discovered that killing cancer cells can actually have the unintended effect of fueling the proliferation of residual, living cancer cells, ultimately leading to aggressive tumor progression.

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma

January 16, 2018
WASHINGTON-(Jan. 16, 2018)-Tumors have come up with ingenious strategies that enable them to evade detection and destruction by the immune system. So, a research team that includes Children's National Health System clinician-researchers ...

Researchers identify new treatment target for melanoma

January 16, 2018
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.